NCT05098132STK-012pembrolizumabmSTK-012cancerNon-small cell lung cancerNSCLC
…ls for first line Non-small cell lung cancer (NSCLC) patients ( NCT05098132) in combination with pembrolizumab and chemotherapy. These find…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: NCT05098132 ×
NCT05098132
This institution is selected. Its supporting articles are shown below.